Clinical trial registry record

Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 15, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07366684
Last registry update
May 15, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
Clinical Center Niš
Enrollment
550
Countries
Serbia
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
550
Population
ALL · 75 Years
Duration
2026-05-13 to 2027-09-01
Intervention
Percutaneous Coronary Intervention (PCI); Conservative Medical Therapy
Comparator
Not reported
Outcomes measured
Impact of treatment strategy (PCI vs conservative therapy) on on all-cause mortality and major adverse cardiovascular e…; Impact of treatment strategy (PCI vs conservative therapy) on hemorrhagic complications — Peri-procedurally (within 48…; Number of Participants with ≥1 All-cause Rehospitalization — 6 months after discharge (± 14 days).; Demographic predictors of conservative management — Baseline (Day 1).; Admission hemoglobin as predictor of conservative management — Baseline.; Admission eGFR (CKD-EPI) as predictor of conservative management — Baseline.; Admission hs-Troponin I as predictor of conservative management — Baseline.; Admission CRP as predictor of conservative management — Baseline.; Admission BNP/NT-proBNP as predictor of conservative management — Baseline.; Admission HbA1c as predictor of conservative management — Baseline.; Composite admission laboratory abnormality score as predictor of conservative management — Baseline.; ECG ischemic changes at admission as predictor of conservative management — Baseline; ECG rhythm and arrhythmias at admission as predictor of conservative management — Baseline.; ECG conduction abnormalities at admission as predictor of conservative management — Baseline; Angiographic high-risk anatomy composite as predictor of conservative management — Peri-procedurally (immediately after…; Left Ventricular Ejection Fraction as predictor of conservative management — At admission (transthoracic echo within 72…; E/e' ratio as predictor of conservative management — At admission (transthoracic echo within 72 hours of admission), va…; Pericardial effusion as predictor of conservative management — At admission (transthoracic echo within 72 hours of admi…; Left Atrial Volume Index as predictor of conservative management — At admission (transthoracic echo within 72 hours of…; Wall Motion Score Index as predictor of conservative management — At admission (transthoracic echo within 72 hours of a…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.